Webinars and Sponsored Roundtables — Register Now

Wednesday, September 23, 2026. 12 PM-1 PM ET
Roundtable presenters Dr. David Sacks MB, ChB, FRCPath, Chairman, Steering Committee National Glycohemoglobin Standardization Program (NGSP), and Priya Sivaraman, PhD, Senior Technical Product Manager, Tosoh Bioscience

CAP TODAY does not endorse any of the products or services named within. The roundtable is made possible by a special educational grant from Tosoh Bioscience Inc.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Thursday, September 24, 2026 11 AM-12 PM CT
This session explores the evolving role of RAS in precision oncology, from the biology of RAS mutations to the expanding landscape of targeted therapies. Through expert presentations, real-world case discussions, and interactive audience polling, participants will examine best practices for RAS biomarker testing across solid tumors, including lung, colorectal, and pancreatic cancers. The session will highlight practical considerations for tissue and liquid biopsy, strategies to address testing gaps, and the importance of multidisciplinary collaboration to ensure timely identification of patients who may benefit from RAS-targeted therapies.

Webinar presenters David Braxton, MD, Chief of Molecular Pathology Services, Hoag Family Cancer Institute & Hoag Memorial Hospital Presbyterian, and Carlos Becerra, MD, Research Director for Medical Oncology, Margaret Given Larkin Endowed Chair for Developmental Cancer Therapeutics, Hoag Memorial Hospital Presbyterian

CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from OncoLens and Diaceutics.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Wednesday, September 30, 2026. 1 PM-1:30 PM ET
Roundtable presenters John Longshore, PhD, Head of Scientific Affairs, Global Oncology Diagnostics, AstraZeneca, and Flora Berisha, MS, Executive Director, Global Head of Diagnostic Partnering and Development, Johnson & Johnson Innovative Medicine, and Mark D. Ewalt, MD, Associate Medical Director for Laboratory Operations, Diagnostic Molecular Pathology, Molecular Diagnostics Service, Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, and Isabel Preeshagul, DO, MBS, Thoracic Medical Oncologist, Memorial Sloan Kettering Cancer Center

CAP TODAY does not endorse any of the products or services named within. The roundtable is made possible by a special educational grant from Pillar Biosciences.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Thursday, October 1, 2026 1 PM-2 PM ET
This presentation will explore the value of in-house CGP, offer insights into the benefits and drawbacks of incorporation, and provide information about important practical factors when considering in-house implementation of CGP.

Webinar presenter Allison M. Cushman-Vokoun, MD, PhD, FCAP, Medical Director, Molecular Diagnostics and Personalized Medicine Laboratory, Director, Division of Diagnostic Molecular Pathology and Human Genetics, Henry F. Krous Professor of Pathology, University of Nebraska Medical Center

CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Illumina.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Tuesday, October 20, 2026 11 AM-12 PM ET
Hear experts review the biological and clinical significance of the HER2 expression continuum in breast tissue, providing a clearer understanding of how these variations might impact diagnosis, and discuss the emerging importance of documenting HER2-low and HER2-ultralow categories using a validated IHC assay.

Webinar presenters Keith Wharton, MD, PhD, Global Medical Affairs Leader–Pathology, Roche Diagnostics Solutions, and Hannah Y. Wen, MD, PhD, Director, Breast Pathology Fellowship, Associate Team Leader, Breast Pathology Team, Attending Pathologist, Memorial Sloan Kettering Cancer Center

CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Roche.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Tuesday, November 3, 2026 1 PM-2 PM ET
Hear an expert discuss the challenges of detecting NRG1 fusions and how RNA-based testing can support more comprehensive fusion identification in clinical practice.

Webinar presenter Benjamin Weinberg, MD, Associate Professor of Medicine and Attending Physician
specializing in gastrointestinal medical oncology

CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Diaceutics.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Subspecialties

Interactive Product Guides

CAP Today Recommends

Grundium White Paper: How Compact, On-Demand Whole-Slide Imaging (WSI) Delivers High-Quality & Timely Diagnoses​

February 2026—Prepared with expert insight from Anil Parwani, MD, PhD; Scott Hammond; and Melinda Schumacher, MD, Grundium’s white paper describes, from a pathologist’s perspective, how compact WSI systems can shorten consult turnaround times and reduce variability, improve access to subspecialty review without adding travel or courier burden, enhance community pathologists’ professional satisfaction and confidence, support scalable, secure, and validated workflows and lay the foundation for AI and advanced analytics as digital adoption grows. Download the white paper here.

Seegene unveils CURECA–100% unattended PCR automation

Seegene introduced CURECA, a fully automated PCR solution that processes diverse specimen types (urine, blood, sputum, and stool) and performs the entire PCR workflow from sample loading to result. CURECA performs the entire PCR testing process without any human intervention, enabling nonstop operation, 24 hours a day, seven days a week. CURECA automatically stops and refills consumables and transfers testing plates to the next step. CURECA configuration can be tailored to specific laboratories that demand particular test types and have space constraints. CURECA offers flexibility in diagnostics, from small-scale to large-scale testing, enabling broad coverage of diseases.

The future of clinical laboratories in value-based care—Is this our tomorrow to lose?

April 2025—Many look to CAP TODAY to be a central disseminator of news, opinion, and other important information, and it has in the past filled that role in response to others’ requests. One such recent request is that of the Clinical Lab 2.0 movement, established in 2017 by the Project Santa Fe Foundation. We present here, for CAP TODAY readers, the Clinical Lab 2.0 movement’s position paper.

Pathology Visions 2024—Decision Digital

The Digital Pathology Association (DPA) invites you to attend this year’s annual meeting, taking place Nov. 3–5 in Orlando, Fla. The theme for Pathology Visions 2024 is “Decision Digital.” Pathology Visions brings together hundreds of pioneers and peers across the field of digital pathology and AI. If you are a clinician, scientist, technician, or trainee, #PathVisions24 is the place for you. “Pathology Visions 2024 promises to be the highlight of the year and an event you won’t want to miss. We have brought together a diverse lineup of speakers who are leaders in their fields, ready to share their insights and breakthroughs.

Clinical Lab 2.0 honors laboratory team excellence

Clinical Lab 2.0, a Project Santa Fe Foundation initiative, released a proclamation during Medical Laboratory Professionals Week, April 14–20, to recognize and celebrate the roles of laboratory medicine and pathology in the field of medicine “as we transition from the business of volume to the business of value” in the delivery of integrated health care. Read the full proclamation here. Clinical Lab 2.0 was established to provide thought leadership and help develop the evidence base for the valuation of clinical

Xifin white paper: a guide to molecular Dx market-share expansion

Xifin released a white paper titled “The Executive’s Guide to Molecular Diagnostic Market-Share Expansion: Critical Success Factors for Maximizing Revenue, Patient Access, and Physician Engagement.” Authors Kyle Fetter, chief operating officer, and Harley Ross, chief commercial officer, offer practical approaches, process enhancements, and payor strategies essential to growing novel diagnostic market share through proactive, purposeful, and technologically enabled engagements with patients, physicians, and payors. Download the white paper here.

 

Amplify the value of your AP LIS

Now available from NovoPath and PathAI is a free webinar that aims to help viewers understand how digital pathology and AI can help an organization. Speakers Eric Walk, MD, Jim Sweeney, and R. Shawn Kinsey, MD, from PathAI and Ed Youssef from NovoPath discuss how digital pathology and AI can streamline your pathology workflows and how some of the largest labs in the United States are already applying these applications. The webinar, titled “Digital pathology and artificial intelligence 101: unlocking value from the AP LIS,” is available through the link here. Registration is required to access the webinar.

Pathology Visions 2023

“Igniting Digital Pathology Transformation”—the theme for Pathology Visions 2023. The Digital Pathology Association (DPA) invites you to attend this year’s annual meeting taking place October 29–31 in Orlando, Fla. Pathology Visions brings together hundreds of pioneers and peers across the field of digital pathology to address real-world, practical applications of digital pathology and AI today, as well as the future. Attendees have access to more than 50 expert presenters, over 70 poster presentations, nearly 50 vendors showcasing the latest innovations, countless opportunities for discussion and engagement, and much more. If you are a clinician, scientist, technician, or trainee #PathVisions23 is the place for you.

Dark Daily to present free webinar on
Z-Code application process

UnitedHealthcare is requiring, effective Aug. 1, that genetic test claims associated with about 250 CPT codes include a Z-Code issued by the MolDx Diagnostic Exchange (DEX) registry, operated by Palmetto GBA, a Medicare administrative contractor. To help clinical labs meet their needs for swift Z-Code registration of their genetic tests, the Dark Report and Dark Daily are presenting a free, 90-minute webinar titled “Essential Guide to Obtaining Z-Codes for Molecular and Genetic Tests” on Thursday, June 29, at 1 pm EDT. The keynote speaker is Gabriel Bien-Willner, MD, PhD, chief medical officer of Palmetto GBA and medical director of the Molecular Diagnostic Services Program (MolDx). He will provide an up-to-the-minute picture of the DEX MolDx Z-Code registry, including the application and documentation processes needed to register a molecular test and obtain a unique Z-Code for that test.

Dark Daily to present free webinar on
Z-Code application process

UnitedHealthcare is requiring, effective Aug. 1, that genetic test claims associated with about 250 CPT codes include a Z-Code issued by the MolDx Diagnostic Exchange (DEX) registry, operated by Palmetto GBA, a Medicare administrative contractor. To help clinical labs meet their needs for swift Z-Code registration of their genetic tests, the Dark Report and Dark Daily are presenting a free, 90-minute webinar titled “Essential Guide to Obtaining Z-Codes for Molecular and Genetic Tests” on Thursday, June 29, at 1 pm EDT. The keynote speaker is Gabriel Bien-Willner, MD, PhD, chief medical officer of Palmetto GBA and medical director of the Molecular Diagnostic Services Program (MolDx). He will provide an up-to-the-minute picture of the DEX MolDx Z-Code registry, including the application and documentation processes needed to register a molecular test and obtain a unique Z-Code for that test.